日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation

作者更正:通过调控细胞凋亡来构建抗BCMA CAR-T细胞以增强其杀伤骨髓瘤细胞的功效。

Kimman, Thomas; Cuenca, Marta; Tieland, Ralph G; Rockx-Brouwer, Dedeke; Janssen, Jasmijn; Motais, Benjamin; Slomp, Anne; Pleijte, Corine; Heijhuurs, Sabine; Meringa, Angelo D; Boschloo, Wendy; Bosma, Douwe M T; Kroos, Sanne; Lo Presti, Vania; Sluijter, Joost P G; Nierkens, Stefan; Bovenschen, Niels; Kuball, Jürgen; van Mil, Alain; Minnema, Monique C; Sebestyén, Zsolt; Peperzak, Victor

Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation.

通过调控细胞凋亡来增强抗BCMA CAR T细胞杀伤骨髓瘤细胞的功效

Kimman Thomas, Cuenca Marta, Tieland Ralph G, Rockx-Brouwer Dedeke, Janssen Jasmijn, Motais Benjamin, Slomp Anne, Pleijte Corine, Heijhuurs Sabine, Meringa Angelo D, Boschloo Wendy, Bosma Douwe Mt, Kroos Sanne, Lo Presti Vania, Sluijter Joost P G, Nierkens Stefan, Bovenschen Niels, Kuball Jürgen, van Mil Alain, Minnema Monique C, Sebestyén Zsolt, Peperzak Victor

Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML

结合 CRISPR-Cas9 和 TCR 交换技术,生成安全有效的脐带血来源 T 细胞产品,用于治疗儿童复发性急性髓系白血病

Vania Lo Presti ,Angelo Meringa ,Ester Dunnebach ,Alice van Velzen ,Aida Valera Moreira ,Ronald W Stam ,Rishi S Kotecha ,Anja Krippner-Heidenreich ,Olaf T Heidenreich ,Maud Plantinga ,Annelisa Cornel ,Zsolt Sebestyen ,Jurgen Kuball ,Niek P van Til # ,S Nierkens #

CRISPR screens decode cancer cell pathways that trigger γδ T cell detection

CRISPR筛选技术能够解码触发γδ T细胞检测的癌细胞通路。

Murad R Mamedov,Shane Vedova #,Jacob W Freimer #,Avinash Das Sahu,Amrita Ramesh,Maya M Arce,Angelo D Meringa,Mineto Ota,Peixin Amy Chen,Kristina Hanspers,Vinh Q Nguyen,Kirsten A Takeshima,Anne C Rios,Jonathan K Pritchard,Jürgen Kuball,Zsolt Sebestyen,Erin J Adams,Alexander Marson

Uncovering the mode of action of engineered T cells in patient cancer organoids

揭示患者癌症类器官中工程化 T 细胞的作用方式

Johanna F Dekkers #, Maria Alieva #, Astrid Cleven, Farid Keramati, Amber K L Wezenaar, Esmée J van Vliet, Jens Puschhof, Peter Brazda, Inez Johanna, Angelo D Meringa, Heggert G Rebel, Maj-Britt Buchholz, Mario Barrera Román, Amber L Zeeman, Sam de Blank, Domenico Fasci, Maarten H Geurts, Annelisa M

Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies

改善γδTCR工程化T细胞疗法治疗实体恶性肿瘤的策略

Meringa, A D; Hernández-López, P; Cleven, A; de Witte, M; Straetemans, T; Kuball, J; Beringer, D X; Sebestyen, Z

Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds

γδTCR抗CD3双特异性分子(GABs)作为新型免疫治疗化合物

van Diest, Eline; Hernández López, Patricia; Meringa, Angelo D; Vyborova, Anna; Karaiskaki, Froso; Heijhuurs, Sabine; Gumathi Bormin, Jan; van Dooremalen, Sanne; Nicolasen, Mara J T; Gatti, Lucrezia C D E; Johanna, Inez; Straetemans, Trudy; Sebestyén, Zsolt; Beringer, Dennis X; Kuball, Jürgen

Identification of a tumor-specific allo-HLA-restricted γδTCR

鉴定肿瘤特异性同种异体HLA限制性γδTCR

Kierkels, G J J; Scheper, W; Meringa, A D; Johanna, I; Beringer, D X; Janssen, A; Schiffler, M; Aarts-Riemens, T; Kramer, L; Straetemans, T; Heijhuurs, S; Leusen, J H W; San José, E; Fuchs, K; Griffioen, M; Falkenburg, J H; Bongiovanni, L; de Bruin, A; Vargas-Diaz, D; Altelaar, M; Heck, A J R; Shultz, L D; Ishikawa, F; Nishimura, M I; Sebestyén, Z; Kuball, J